상세 보기

Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20-17/KM23 trial

Lee, Kyoungmin;
Lee, Kyung-Hun;
Kim, Dong-Wan;
Yoon, Jeesun;
Choi, Yoon Ji;
... Lee, Soohyeon;
... Kim, Ju Won;
... Park, Kyong Hwa;
... Kang, Eun Joo;
... Park, In Hae;
외 11명

Citations

WEB OF SCIENCE

2

Citations

SCOPUS

2

초록

[No abstract available]

키워드

CANCER

제목: Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20-17/KM23 trial

저자: Lee, Kyoungmin; Lee, Kyung-Hun; Kim, Dong-Wan; Yoon, Jeesun; Choi, Yoon Ji; Lee, Soohyeon; Kim, Ju Won; Park, Kyong Hwa; Choi, Wonyoung; Lee, Youngjoo; Ryu, Hyewon; Koo, Dong-Hoe; Lee, YunGyoo; Jeung, Hei-Cheul; Lee, Min-Young; Lee, Namsu; Kang, Myoung Joo; Lee, Jieun; Hong, Sook Hee; Kang, Eun Joo; Park, In Hae

DOI: 10.1002/cac2.70026

발행일: 2025-04

유형: Article in press

저널명: Cancer Communications

권: 45

호: 7

페이지: 841 ~ 845

언어: ENG

출판사: Wiley

발행국가: 미국

분량: 5 페이지

ISSN: E 2523-3548
P 2523-3548